Detalhe da pesquisa
1.
Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review.
J Am Soc Nephrol
; 34(12): 1928-1935, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807165
2.
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.
J Am Soc Nephrol
; 33(4): 850-866, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361724
3.
Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study.
J Am Soc Nephrol
; 32(3): 737-755, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33568383
4.
Inverse Correlation between the Atrial Fibrillatory Rate and the Ventricular Repolarization Time: Observations at Baseline and after an Intravenous Infusion of a Combined Potassium and Sodium Current Blocker.
Ann Noninvasive Electrocardiol
; 21(3): 236-45, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26246430
5.
Is the acetylcholine-regulated inwardly rectifying potassium current a viable antiarrhythmic target? Translational discrepancies of AZD2927 and A7071 in dogs and humans.
Europace
; 17(3): 473-82, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25082948
6.
Rapid slowing of the atrial fibrillatory rate after administration of AZD7009 predicts conversion of atrial fibrillation.
J Electrocardiol
; 47(3): 316-23, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24508473
7.
Assessment of ventricular repolarization variability with the DeltaT50 method improves identification of patients with congenital long QT syndromes.
Ann Noninvasive Electrocardiol
; 18(3): 240-50, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23714082
8.
Decrease of the atrial fibrillatory rate, increased organization of the atrial rhythm and termination of atrial fibrillation by AZD7009.
J Electrocardiol
; 46(1): 29-35, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23219385
9.
Retraction notice to "Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis." Kidney Int Rep. 2021;6:613-623.
Kidney Int Rep
; 7(3): 665, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35257087
10.
Pharmacological cardioversion of atrial fibrillation--a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously.
Europace
; 13(8): 1148-56, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21561900
11.
DeltaT50--a new method to assess temporal ventricular repolarization variability.
J Electrocardiol
; 44(4): 477.e1-9, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21704223
12.
Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.
Clin J Am Soc Nephrol
; 16(8): 1190-1200, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34362786
13.
Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.
Kidney Int Rep
; 6(3): 613-623, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33732976
14.
Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.
Stroke
; 41(12): 2731-8, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20966417
15.
A randomized invasive cardiac electrophysiology study of the combined ion channel blocker AZD1305 in patients after catheter ablation of atrial flutter.
J Cardiovasc Pharmacol
; 56(3): 300-8, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20588189
16.
Prediction of drug-related morphological changes of the T wave.
Scand Cardiovasc J
; 44(4): 215-22, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20429697
17.
Disparate stroke rates on warfarin among contemporaneous cohorts with atrial fibrillation: potential insights into risk from a comparative analysis of SPORTIF III versus SPORTIF V.
Stroke
; 39(11): 3009-14, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18703812
18.
Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
Am Heart J
; 155(2): 382-7, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18215612
19.
Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials.
Stroke
; 38(11): 2965-71, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17885258
20.
Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials.
Eur J Heart Fail
; 9(6-7): 730-9, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17360232